<code id='559C7616AC'></code><style id='559C7616AC'></style>
    • <acronym id='559C7616AC'></acronym>
      <center id='559C7616AC'><center id='559C7616AC'><tfoot id='559C7616AC'></tfoot></center><abbr id='559C7616AC'><dir id='559C7616AC'><tfoot id='559C7616AC'></tfoot><noframes id='559C7616AC'>

    • <optgroup id='559C7616AC'><strike id='559C7616AC'><sup id='559C7616AC'></sup></strike><code id='559C7616AC'></code></optgroup>
        1. <b id='559C7616AC'><label id='559C7616AC'><select id='559C7616AC'><dt id='559C7616AC'><span id='559C7616AC'></span></dt></select></label></b><u id='559C7616AC'></u>
          <i id='559C7616AC'><strike id='559C7616AC'><tt id='559C7616AC'><pre id='559C7616AC'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:674
          A tumor invasion into vein in a case of colorectal cancer -- cancer coverage from STAT
          A tumor invasion into a vein in a case of colorectal cancer. Wikimedia Commons

          When both the nurse and the doctor broke down in tears as they delivered the news, Chris Gosline knew that something difficult lay ahead.

          It was 5 a.m., after a long night in the emergency department at Beverly Hospital, where he’d gone for help with severe pain in his shoulder. A scan had detected tumors on his liver. Turns out, there’s a nerve connection that makes shoulder pain a possible sign of liver disease.

          advertisement

          Further testing over the next couple of weeks clarified the cause: Gosline had stage 4 colorectal cancer, which had spread to his liver.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Colonoscopy prep: Liquid

          AdobeSincecolorectalcancerisontheriseinpeopleyoungerthanage50,nationalguidelineshaverecentlypushedth